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Selection of a minor viral genotype during perinatal transmission of human Immunodeficiency virus type 1
(HIV-1) has been observed, but there is a lack of information on the correlation of the restrictive transmission
with biological properties of the virus, such as replicative fitness. Recombinant viruses expressing the en-
hanced green fluorescent protein or the Discosoma sp. red fluorescent (DsRed2) protein carrying the V1 to V5
regions of env from seven mother-infant pairs (MIPs) infected by subtype C HIV-1 were constructed, and
competition assays were carried out to compare the fitness between the transmitted and nontransmitted
viruses. Flow cytometry was used to quantify the frequency of infected cells, and the replicative fitness was
determined based on a calculation that takes into account replication of competing viruses in a single infection
versus dual infections. Transmitted viruses from five MIPs with the mothers chronically infected showed a
restrictive env genotype, and all the recombinant viruses carrying the infants’ Env had higher replicative fitness
than those carrying the Env from the mothers. This growth fitness is lineage specific and can be observed only
within the same MIP. In contrast, in two MIPs where the mothers had undergone recent acute infection, the
viral Env sequences were similar between the mothers and infants and showed no further restriction in
quasispecies during perinatal transmission. The recombinant viruses carrying the Env from the infants’
viruses also showed replication fitness similar to those carrying the mothers’ Env proteins. Our results suggest
that newly transmitted viruses from chronically infected mothers have been selected to have higher replicative
fitness to favor transmission, and this advantage is conferred by the V1 to V5 region of Env of the transmitted
viruses. This finding has important implications for vaccine design or development of strategies to prevent
HIV-1 transmission.
Perinatal transmission of human immunodeficiency virus
type 1 (HIV-1) accounts for 90% of infections in infants world-
wide, and it occurs in 30 to 45% of children born to untreated
HIV-1-infected mothers. This is especially significant in sub-
Saharan Africa where HIV-1 infection is epidemic, and anti-
retroviral treatment is still not widely available (1). The HIV-1
subtypes that are transmitted in the region are also different
from those found in developed countries, with subtype C being
the most prevalent. Understanding the viral factors that influ-
ence perinatal transmission of subtype C virus is thus critical
for development of strategies to prevent transmission. How-
ever, much of the accumulated knowledge on transmission
comes from studies of cases of subtype B infection which have
focused on adult donors who were chronically infected. Very
little is known about the transmission in the context of mother-
to-child transmission, and the applicability of such findings to
subtype C remains to be determined. Several studies in adult
donors have shown that only a limited number of viruses within
the viral quasispecies population are transmitted from the do-
nor, suggesting that minor viral species are transmitted (8, 11).
Similar observations were made with perinatal transmission
(34, 37, 40).
A number of factors have been suggested to affect the trans-
mission of specific viral species. Genetic analyses of the env
gene have suggested selective transmission of R5-utilizing
HIV-1 during perinatal transmission from chronically infected
donors (37, 40). However, other analyses have shown a sto-
chastic pattern with transmission of multiple and/or major ma-
ternal HIV-1 variants (10, 19, 24). It has also been suggested
that the virus variants more resistant to neutralization are
preferentially transmitted perinatally (33). Neutralizing anti-
body response in the host may be associated with a replicative
cost to the virus, and a compromise for the virus between
immune escape and replication adaptability to the host could
occur (5, 9, 28). It is likely that other biological properties of
the virus may play roles to favor perinatal transmission; such
properties may include enhanced viral replicative fitness of the
transmitted viruses.
HIV-1 replicative fitness is related to pathogenicity, viru-
lence, drug-resistant mutations, and disease progression (4, 13,
30, 35). The fitness of different HIV-1 subtypes was also found
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to correlate with their prevalence in the human population (17,
26, 31). Despite these observations, the association between
HIV-1 replicative fitness and transmission is poorly defined,
and information addressing an association with perinatal trans-
mission is essentially nonexistent. Since, in the absence of drug
treatment, HIV-1 replicative fitness is largely determined by
the functions of Env (4, 22, 31), it is anticipated that replicative
fitness might also impact virus transmission. This concept has
heretofore not been tested, and therapy-naive mother-infant
pairs (MIPs) in our study provide a unique opportunity to
examine the properties of transmitted viruses from mother to
child. As the perinatally transmitted virus should be the target
of vaccine strategies, information on its biological phenotype
could be directly relevant to the development of a vaccine.
Such information also provides insight into mechanisms to
prevent such transmission.
We have been studying a Zambian mother-infant cohort for
perinatal transmission of subtype C HIV-1 and have analyzed
the viral env quasispecies of several MIPs during perinatal
transmission. We found that there was a reduction in the viral
quasispecies during perinatal transmission from mothers who
were chronically infected (41). In contrast, such a reduction
was not observed in mothers who were acutely infected (14). In
this study, we investigated the fitness of the viral Env, which
may affect perinatal transmission, from seven MIPs infected by
subtype C HIV-1. Five pairs were from a chronically infected
source, and the other two pairs were from an acutely infected
source. We found that recombinant viruses carrying the V1 to
V5 region of Env of the infant viruses from all chronically
infected MIPs have higher replicative fitness levels than the
viruses infecting the mothers. In contrast, as expected, the Env
from the acutely infected MIPs did not show such properties
since both the mother and infant viruses had undergone recent
transmission. Our results suggest that the Env protein affects
viral fitness, which plays a role in perinatal transmission. Here,
we show that transmitted viruses have biological properties,
such as enhanced replicative fitness, that favor perinatal trans-
mission and may provide new targets for intervention.
MATERIALS AND METHODS
Patient information and sample collection. HIV-1 from seven HIV-1-infected
MIPs was studied. The mothers of five MIPs (pairs 2617, 1449, 1084, 2669, and
2873) were found to be infected at delivery, possibly by sexual transmission, and
their infants were determined by PCR to be infected at either 2 months (pairs
2617, 1449, 2669, and 2873) or 4 months (1084) after birth. The infants were
either infected in utero/intrapartum or through breast-feeding. These five MIPs
were defined as the chronically transmitted MIPs. For the other two MIPs (pairs
834 and 2660), mothers and infants were found to have seroconverted at the
same follow-up time point after birth. MIPs 834 and 2660 were found to be
infected at 4 and 18 months after birth, respectively. They were defined as acutely
infected MIPs, where the mothers were infected via sexual contact and the
infants were infected through breast-feeding. The baseline HIV-1 serological
status of the mothers was determined at delivery by two rapid assays, Capillus
(Cambridge Biotech, Ireland) and Determine (Abbott laboratories). Positive
serological results were confirmed by immunofluorescence assay as previously
described (20). Informed consent and human subject protocols were approved by
the University of Nebraska-Lincoln Institutional Review Board and the Univer-
sity of Zambia, School of Medicine Research Ethics Committee.
Cell and virus cultures. 293T and TZM-bl cells were obtained from the NIH
AIDS Research and Reference Reagent Program and maintained in Dulbecco’s
modified Eagle’s medium (DMEM) with 10% fetal bovine serum (FBS) and 100
g/ml penicillin-streptomycin. U87-CD4-CCR5 cells (kindly provided by Lee
Ratner, Washington University) were propagated in DMEM supplemented with
10% FBS, 4 mM L-glutamine, 1 mM sodium pyruvate, 200 g/ml G418, and 1
g/ml puromycin (27). The 50% tissue culture infective dose of each recombi-
nant virus stock was determined by infecting TZM-bl cells (39) with fourfold
serial dilutions of virus as described previously (21).
Cloning and expression of Env glycoprotein. The cloning of the V1 to V5
(V1-V5) regions of env derived from patients and the sequences of the Env
clones used for this study were described previously (41). For the chronically
infected MIPs (pairs 2617, 1449, 1084, 2669, and 2873), maternal samples col-
lected at delivery and infant samples collected at the first postpartum HIV-1
PCR-positive time point were defined as baseline specimens. For acutely in-
fected MIPs (pairs 834 and 2660), the baseline specimens were obtained at the
time of seroconversion. For this study, the env V1-V5 regions were subcloned
from the selected clones by amplifying the insert from the pGEM-T Env clones
using the sense primer C-DraIII (5-TGACCCCACTCTGTGTCACTTTA-3)
or C-PshAI (5-TGGGACCAAAGTCTAAAGCCATGTGT-3) and antisense
primer C-AvrII (5-CTATTCCTAGGGGCTTAATTTCTACCACTT-3) con-
taining restriction enzyme DraIII/PshAI and AvrII sites for further subcloning.
PCR was carried out at 95°C for 2 min, followed by 25 cycles at 95°C for 30 s,
55°C for 30 s, and 68°C for 1 min, followed by 1 cycle at 68°C for 7 min. The
amplified products were subcloned into pSP72 NLA/S/Av (envelope gene of
NL4.3 modified with AgeI/SbfI/AvrII for cloning purposes) shuttle vector and
pSRHS NLA/S/Av expression vector to determine if the Env sequences were
functional by fusion analysis. Env was expressed as a chimeric protein with the
patient’s Env V1-V5 region and HIV-1 strain NL4.3. Fusion assays were carried
out as described previously (8). Between four and seven representative func-
tional and fusion-positive Env clones from each MIP baseline were available for
the growth competition analysis.
Generation of recombinant HIV-1 expressing EGFP or DsRed2 fluorescent
proteins. To generate enhanced green fluorescent protein (EGFP)-tagged or
Discosoma sp. red fluorescent protein (DsRed2)-tagged recombinant HIV-1, the
entire chimeric env was amplified from the pSP72 NLA/S/Av or pSRHS NLA/
S/Av plasmid clones with sense primer EnvB-F (5-AGAAAGAGCAGAAGA
CAGTGGCAATGA-3) and antisense primer EnvB-R (5-TTGTACTACTTC
TATAACCTTATCTGT-3). The PCR parameters were 1 cycle at 95°C for 2
min; 30 cycles at 95°C for 30 s, 55°C for 30 s, and 68°C for 2 min and 30 s; and
1 cycle at 68°C for 10 min. The NL4.3EnvEGFP or NL4.3EnvDsRed2 vectors
(kindly provided by Miguel E. Quinones-Mateu, Case Western Reserve Univer-
sity) were linearized with XbaI (New England Biolabs) and used as the backbone
for the generation of recombinant viruses with the Env fragments. The EGFP- or
DsRed2-tagged recombinant viruses were generated by cotransfecting equal molar
amounts of the PCR-amplified entire env fragment and linearized NL4.3EnvEGFP
or NL4.3EnvDsRed2 vector into 293T cells (at a density of 2.5  106 cells/per
10-cm culture dish) with FuGENE 6, according to the manufacturer’s protocol
(Roche, Indianapolis, IN). Culture supernatants were harvested at 60 h posttrans-
fection, filtered through 0.45-m-pore-size sterile syringe filters (Millipore), and
stored at 80°C for titration and growth competition analyses.
Growth competition assays for evaluation of viral fitness. Growth competition
experiments involve coinfection of a cell culture by the different HIV isolates. In
our assays, cells were exposed to a mixture of two viruses or to each of the two
virus individually; the number of cells infected by each virus in the dual infection
after several rounds of infection was compared to the number of infected cells
during monoinfection by each of the two viruses (7, 25, 29, 30). Single infection
and competition experiments were performed in triplicate with EGFP- or
DsRed2-tagged recombinant viruses using TZM-bl or U87-CD4-CCR5 cells
grown in 24-well cell culture plates. NL4.3 EGFP- or DsRed2-tagged recombi-
nant viruses were used as positive controls. Cells were infected with two com-
peting viruses at an equal multiplicity of infection (MOI): 0.01 for TZM-bl and
0.005 for U87-CD4-CCR5 cells. Infections were carried out with 5  104 cells/
well in 24-well cell culture plates at 37°C and 5% CO2 for 24 h. The cells were
washed three times with phosphate-buffered saline and then cultured in com-
plete DMEM until harvesting. For the infection of peripheral blood mononu-
clear cells (PBMC), the PBMC from HIV-seronegative blood donors were ob-
tained by Ficoll-Hypaque density gradient centrifugation of heparin-treated
venous blood. Prior to HIV-1 infection, the cells were stimulated with 5 g of
phytohemagglutinin (Gibco BRL) per ml for 3 days and maintained in RPMI
1640 medium supplemented with 10% FBS (HyClone) and 10 U/ml of interleu-
kin-2 (Gibco-BRL). All mono- and dual-infection/competition experiments were
performed at an MOI of 0.001 in PBMC in triplicate. Following a 6-h incubation
at 37°C with 5% CO2, cells were washed three times with 1 phosphate-buffered
saline and then resuspended in complete medium (106/ml) on 24-well plates. At
14 days postinfection, viruses were harvested and analyzed.
Quantitation of cells infected with EGFP- or DsRed2-tagged HIV-1 by flow
cytometry. Infection was monitored daily for the presence of fluorescent cells
using a Eclipse TE300 inverted upright wide-field fluorescence microscope
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(Nikon, Japan). Optimal signal of the cells infected with EGFP- or DsRed2-
tagged HIV-1 from both single and dual infections was observed at 5 days
postinfection. Cells were then harvested and analyzed by flow cytometry using a
FACSCalibur instrument and Cell Quest Pro software (Becton Dickinson).
Evaluation of viral fitness. The fitness values were calculated based on the
amounts of viruses produced during dual infections compared to amounts ob-
tained from monoinfections. The amount of virus produced was determined by
counting the number of cells that were infected by either the green- or red-
tagged virus at 5 days postinfection using flow cytometry. In our HIV-1 compe-
tition experiments, the initial ratio of the competing viruses was 1:1. The fitness
values were calculated with the formula shown in Fig. 1C. The amount of an
individual HIV-1 isolate in a dual infection at the end of competition (f0) was
divided by the amount of the same virus resulting from a monoinfection assay
(i0), using the same initial inoculum as in the competition assay to derive a
single-virus fitness value, W (W  f0/i0). The relative fitness value (W) for each
virus was obtained from the average of the triplicate results in the competition
assay. The ratio of the relative fitness value of each HIV-1 variant in the com-
petition is a measurement of the fitness differences (Wd) between the infant and
maternal viruses (Wd  Wi/Wm), where Wi and Wm correspond to the relative
fitness of the infant and maternal viruses, respectively (30). Any variation in
quantitation efficiency of flow cytometry was compensated by dividing the level
of fluorescence of the specific virus from competition by the level of fluorescence
from a single infection (2).
Nucleotide sequence analysis and divergence analyses. The pSP72 NLA/S/Av
or pSRHS NLA/S/Av clones containing env V1-V5 were confirmed by sequence
analysis using primers EnF1 (5-GATGCATGAGGATATAATCAGTTTATG
GGA-3) and EnR1 (5-ATTGATGCTGCGCCCATAGTGCT-3). Sequence
analyses were carried out using an ABI Prism BigDye 3 terminator cycle se-
quencing ready reaction kit (Applied Biosystems). Sequence data were manually
edited with Sequencher, version 4.6 (Gene Codes Corporation). Neighbor-join-
ing trees based upon Kimura two-parameter distance matrices were constructed
using the MEGA3 software package (18). The most recent common ancestor
FIG. 1. Construction of EGFP/DsRed2-tagged recombinant HIV-1 and fitness analysis. (A) Generation of HIV-1-EGFP/DsRed2-tagged
recombinant viruses. PCR-amplified products of the entire env fragment were cotransfected with Xba1-linearized HIV-1 NL4.3env EGFP/
DsRed2 backbone vector into 293T cells. Viruses were harvested at 60 h after cotransfection. LTR, long terminal repeat. (B) Competition assay.
Virus was added alone or in pairs to U87-CD4-CCR5 cells at an equal MOI of 0.005. Cells were harvested at day 5 postinfection and analyzed
by fluorescence-activated cell sorter analysis. R, DsRed2-tagged virus; G, EGFP-tagged virus. (C) Relative fitness values calculation. Relative
fitness values were calculated as shown. FL1 is the background intensity on the EGFP detector in a culture infected by a DsRed2-tagged virus (R),
and FL2 is the background intensity on the DsRed2 detector in a culture infected by a EGFP-tagged virus (G). The number in the quadrant shows
the percentage of green or red fluorescent cells in each single or dual infection. (D) EGFP and DsRed2 expression level in TZM-bl cells after single
or dual infection with HIV-1 NL4.3 EGFP- or HIV-1 NL4.3 DsRed2-tagged recombinant viruses at an MOI of 0.01. The bars show the percentage
of cells expressing EGFP or DsRed2 in each single or dual infection. (E) The relative fitness values of NL4.3 EGFP and DsRed2 viruses,
respectively. (F) Analysis of dual infection/competition. HIV-1 NL4.3 DsRed2 competed against two randomly selected subtype C EGFP-tagged
recombinant viruses in TZM-bl cells. The bars show the relative replicative fitness value of each virus. The scale of the y axis is 0.4, with higher
relative fitness values above 1 and lower relative fitness values below 1.
VOL. 82, 2008 REPLICATIVE FITNESS IN PERINATALLY TRANSMITTED HIV-1 11611
(MRCA) of the env sequences from the previously available sample was recon-
structed using maximum likelihood in GARL1 (41, 42). Divergence was defined
as the pairwise distance between the individual sequence and the MRCA from
the virus population.
Statistical analyses. A Shapiro-Wilk test was used to analyze the pattern of
distribution of fitness values. A relative fitness value (W) and standard deviation
of relative fitness values were calculated for each MIP; the statistical significance
between two different groups of MIPs was determined by the Student paired t
test. P values of 0.05 were considered to be significant.
RESULTS
Testing and validation of the recombination and competi-
tion assay system. Chimeric recombinant viruses containing
the Env V1-V5 region derived from the MIPs in the subtype B
clone NL4.3 backbone, expressing EGFP or DsRed2 protein,
were constructed and utilized in a dual infection competition
assay (Fig. 1A). The relative fitness of each Env chimeric virus
was determined by infecting U87-CD4-CCR5 cells with viruses
tagged with either EGFP or DsRed2 (Fig. 1B). Flow cytometry
was used to quantify the frequency of infected cells, and the
relative fitness value was calculated based on the amount of
virus produced in the single- versus dual-infection assay (Fig.
1C). To validate the dual-infection assay, we first determined
whether the recombinant viruses with the fluorescent tag were
replication competent using standard HIV-1 subtype B NL4.3
Env recombinant viruses carrying the EGFP or DsRed2 tag.
As expected, both were replication competent and generated
similar growth kinetics in TZM-bl cells, with virus production
increased exponentially and reaching a maximum at day 5
postinfection (data not shown). Harvesting the cells earlier
gave a much weaker signal and was not optimal for fitness
determination in the competition assay. Since both recombi-
nant viruses are identical except for the fluorescent protein
gene, we tested whether they possessed equivalent replicative
fitness in competitions. Indeed, they have the same relative
fitness value (W of 1.0) regardless of the marker they carry
(Fig. 1E). The DsRed2 label consistently gave a weaker fluo-
rescence signal than EGFP either in the single- or dual-infec-
tion assay (Fig. 1D), but this did not adversely affect the overall
replicative fitness value (Fig. 1E). The weaker fluorescent sig-
nal for DsRed2 is due to suboptimal excitation of the protein
by the 488-nm laser line of the cytometer.
To further validate the assay, dual infections were carried
out between NL4.3 and subtype C Env chimeric viruses from
our patients. Based on published studies (4), we anticipated
that subtype B NL4.3 would outcompete recombinant subtype
C viruses. As expected, NL4.3 outcompeted a representative
recombinant subtype C virus (Fig. 1F), irrespective of whether
DsRed2 or EGFP was used to identify the subtype C virus and
the NL4.3 virus in the dual infection. Hence, the replicative
fitness variation between the two competing viruses is attrib-
uted to differences in Env and not due to the viral backbone or
the fluorescent tags.
The infant recombinant viruses are more fit than the ma-
ternal recombinant viruses from chronically infected MIPs.
We had previously characterized the env genes from the five
infants whose mothers were chronically infected (41). The phy-
logenetic analyses of Env V1-V5 sequences showed that the
baseline infant viruses were more homogeneous than the
mothers’ in five MIPs where mothers were infected with HIV-1
chronically; a representative example of them is shown in Fig.
2A. This indicates either that selective transmission of a minor
viral population occurred during perinatal transmission from
each of these chronically infected mothers or that multiple
HIV-1 variants may have entered the recipient but only minor
variants were selectively amplified. To determine whether the
replicative fitness of transmitted viruses in the infants was
different from those in the maternal donor population, dual-
infection competitions were performed between viruses carry-
ing different maternal and infant viral env genes from the five
MIPs that were previously analyzed (41). The env clones were
selected in each MIP based on the following criteria: (i) the
length of the Env V1-V5 fragment, (ii) the branch length of
each Env in the phylogenetic tree, and (iii) the number of
putative N-linked glycosylation sites. Four to seven env clones
were selected from both the mother and the infant to generate
recombinant viruses. To eliminate the possibility that the se-
lected clones for the competition assay could be outliers, we
then calculated the divergence for each selected clone of the
MIP as the genetic distance between any sequence and the
MRCA of the total previously analyzed archived virus se-
quences (41). The results showed that divergence from each
selected env is within the range of the characterized popula-
tion, and no outlier of divergence was used in our competition
assays. As expected, the analyses of the representative MIP
2873 showed that divergence in pairwise comparison of the
individual sequence and MRCA is somewhat higher in the env
of the maternal viruses than the env of infant viruses, with the
divergence distribution in the infant being more homogeneous
(Fig. 3A and B). The divergence within each individual ranged
from 0.001 to 0.043 (median, 0.007) and 0.001 to 0.008 (me-
dian, 0.002) in mother and infant, respectively. Similar results
were obtained for the other four chronically infected MIPs
(data not shown).
The Env clones from infant 1084 were first used to generate
FIG. 2. Phylogenetic analysis of HIV-1 Env V1-V5 sequences ob-
tained from the baseline time point of two representative MIPs.
(A) MIP 2873 is a representative of a chronically infected MIP de-
scribed previously (41). (B) MIP 2660 is a representative of an acutely
infected MIP described previously (14). Samples from infants are
shown in filled symbols, and samples from mothers are shown in open
symbols.
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DsRed2-tagged recombinant viruses and tested against EGFP-
tagged recombinant viruses from mother 1084 (Fig. 4A). Sta-
tistical analysis showed that the fitness values were distributed
normally (Shapiro-Wilk test, P  0.05). Interestingly, a higher
replicative fitness was consistently observed with all 1084 infant
recombinant viruses than for the maternal variants (Fig. 4B
and Table 1). Dual-infection assays were also carried out using
viruses with the reciprocal Env and fluorescent protein com-
binations, and the same outcomes were observed (Fig. 4C and
D). In general, viruses from infant 1084 outcompeted the ma-
ternal viruses, with fitness differences (Wd) ranging from 1.45-
to 2.64-fold (median, 2.03-fold) in the dual-infection cultures
(Table 1), and significant differences were evident (P  0.05,
Student paired t test) for all except one MIP (i6-3 versus M0-4;
i indicates infant virus and M indicates maternal virus in all
designations). Similar results were obtained with the other four
chronically infected MIPs, including MIPs 1449 (Wd range,
1.31 to 2.23; median, 1.83), 2669 (Wd range, 1.27 to 2.64;
median, 1.60), 2617 (Wd range, 1.13 to 3.35; median, 1.99), and
2873 (Wd range, 1.56 to 5; median, 2.52) (Fig. 5A to D). The
relative fitness values (W) of infants’ HIV-1 viruses were sig-
nificantly higher than those of the mothers’ (see Tables S1 to
S4 in the supplemental material). Recombinant viruses from
infants significantly outcompeted their corresponding maternal
viruses, regardless of the target cell line (TZM-bl or U87-CD4-
CCR5) used in 39 of the 42 pairwise competitions performed
(P  0.05, Student paired t test). To further confirm our re-
sults, pairwise HIV-1 competitions between MIP 1084 mater-
nal and infant Env chimeric viruses were repeated in PBMC
derived from an HIV-1-negative donor. Similar to the results
from cell lines, higher fitness values from infant viruses were
observed in the primary cells (Fig. 4E and F and Table 2). The
fitness differences (Wd) ranged from 1.13 to 2.7 (median, 2.17).
This result further suggests that the superior fitness observed
for infant viruses is not a function of receptor overexpression
on cell lines and is independent of the cell types utilized.
FIG. 3. Divergence of the selected clones from the MRCA env
sequences from a representative chronically infected MIP (2873) and
a representative acutely infected MIP (2660). Pairwise comparisons
between each individual maternal (A) and infant (B) viral Env from
MIP 2873 and MRCA are arbitrarily distributed along the x axis.
Pairwise comparisons between each individual maternal (C) and infant
(D) viruses from MIP 2660 and MRCA are arbitrarily distributed
along the x axis. Samples selected for this study are indicated by the
arrows.
FIG. 4. The competition assays of mother and infant viruses from representative chronically infected MIP 1084 with different fluorescence tags
in U87-CD4-CCR5 cells and in PBMC. (A) A representative of pairwise competition of MIP 1084 at the baseline time point in U87-CD4-CCR5
cells at an MOI of 0.005 (mother, EGFP-tagged viruses; infant, DsRed2-tagged viruses). (B) The relative fitness values of recombinant viruses
obtained from chronically infected MIP 1084 in U87 cells. (C) A representative of pairwise competition of MIP 1084 viruses using reciprocal
fluorescence tags at a baseline time point in U87-CD4-CCR5 cells at an MOI of 0.005 (mother, DsRed2-tagged viruses; infant, EGFP-tagged
viruses). (D) The relative fitness values of recombinant viruses obtained from chronically infected MIP 1084 in reciprocal fluorescence tags in U87
cells. (E) A representative of pairwise competition of MIP 1084 at the baseline time point in PBMC at an MOI of 0.001. (F) The relative fitness
values of recombinant viruses obtained from chronically infected MIP 1084 in PBMC.
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Higher fitness is an intrinsic property of all newly acquired
infant Env glycoproteins. Since all the infant Env variant vi-
ruses outcompeted the representatives derived from the cor-
responding maternal quasispecies, it was of interest to deter-
mine if higher fitness is an intrinsic property of all newly
acquired infant Env glycoproteins. To investigate this possibil-
ity, representative viruses from each infant were tested against
representative viruses from mothers with whom they shared no
linkage via transmission. We found that not all infant viruses
outcompeted all maternal viruses (Table 3). The virus 1084i6-2
from infant 1084 outcompeted the maternal virus 1084M0-4,
with the highest fitness difference (Wd) of 4.26; lower fitness
differences were obtained with 2669M0-2 (Wd of 2) and
TABLE 1. Relative fitness value from pairwise competition of
viruses from MIP 1084 in U87-CD4-CCR5 cellsa
Pair no. and
virus variant W SD Wd P
Pair 1
M0-1 0.7 0.1 2.03 0.01
i6-1 1.3 0.1
Pair 2
M0-1 0.8 0.1 1.62 0.002
i6-2 1.2 0.1
Pair 3
M0-1 0.6 0.1 2.64 0.002
i6-3 1.5 0.1
Pair 4
M0-3 0.6 0 2.02 0.03
i6-2 1.3 0.2
Pair 5
M0-3 0.7 0.1 1.78 0.002
i6-3 1.3 0.1
Pair 6
M0-4 0.6 0 2.28 0.05
i6-1 1.4 0
Pair 7
M0-4 0.8 0.1 1.45 0.004
i6-2 1.2 0.1
Pair 8
M0-4 0.6 0.1 2.17 0.06
i6-3 1.4 0.1
a The W values and standard deviations (SD) were derived from triplicate
competition assays as shown in Fig. 4B. Wd indicates the fitness difference
between infant and maternal viruses as calculated by the relative fitness value of
infant divided by the relative fitness value of mother. A Wd of 	1 indicates that
infant virus is more fit than maternal virus; a Wd of 1 indicates infant virus is
less fit than maternal virus. A two-tailed Student paired t test was used to
determine the statistical difference between mother and infant values. A P value
of 0.05 was considered to be statistically significant.
FIG. 5. The competition assays of mother and infant viruses from chronically and acutely infected MIPs. (A to D) The relative fitness values
of recombinant viruses obtained from chronically infected MIPs 1449, 2669, 2617, and 2873 at the baseline time point in U87-CD4-CCR5 cells at
an MOI of 0.005. (E and F) The relative fitness values of recombinant viruses obtained from acutely infected MIPs 834 and 2660. The gray bars
represent infant viruses; the white bars represent maternal viruses from each pair. All competition experiments were performed in triplicate, and
the error bars indicate standard deviation (SD) from triplicate results.
TABLE 2. Relative fitness value (W) from pairwise competition of
viruses from MIP1084 in PBMC
Pair no. and
virus variant W SD Wd P
Pair 1
M0-1 0.6 0 2.17 0.002
i6-1 1.4 0
Pair 2
M0-1 0.9 0 1.24 0.04
i6-2 1.1 0
Pair 3
M0-1 0.5 0.1 2.7 0.005
i6-3 1.5 0.1
Pair 4
M0-3 0.9 0 1.13 0.03
i6-2 1.1 0
Pair 5
M0-3 0.7 0.2 1.94 0.07
i6-3 1.3 0.2
Pair 6
M0-4 0.6 0.1 2.3 0.02
i6-1 1.4 0.1
Pair 7
M0-4 0.7 0 1.94 0.006
i6-2 1.3 0
Pair 8
M0-4 0.8 0.1 2.7 0.04
i6-3 1.2 0.1
a The W values and standard deviations (SD) were derived from triplicate
competition assays as shown in Fig. 4F. For an explanation of the other values,
see the footnote to Table 1.
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1449M0-3 (Wd of 1). Interestingly, 1084 i6-2 was outcompeted
by nonidentical maternal viruses 2617M0-2 and 2873M0-1.
Similar results were obtained with other infant viruses. These
results suggest that the fitness advantage is lineage specific and
can be observed only within the same MIP; the transmitted
virus in the infants is derived from the maternal virus popula-
tion but has been selected for consistently higher fitness. This
trait does not imply that the transmitted viruses are universally
more fit but likely reflects the overall fitness of the viral lineage
in the transmission chain.
The replicative fitness values of the infant recombinant vi-
ruses are similar to their mothers’ viruses in each acutely
infected MIP. We have recently analyzed the env diversity of
three acutely infected MIPs whose mothers have transmitted
HIV-1 to the infants shortly after being infected themselves.
We found that the viral Env protein sequences from the moth-
ers’ and infants’ viruses did not phylogenetically segregate, and
the infants did not possess a less diverse quasispecies (Fig. 2B)
(14). These analyses suggest that no further restriction of the
viral quasispecies occurred during transmission. This is possi-
bly due to the absence of preexisting immunity and high viral
loads present during acute infection of the mother. Alterna-
tively, the virus recently transmitted to the mother had already
undergone selection and was therefore more readily transmis-
sible to a child undergoing exposure. A corollary to this
premise is that one would not expect to detect differences in
viral fitness, on average, between maternal and infant Env
variants derived from such an acutely infected pair. To test this
supposition, several previously characterized env clones were
selected from the acutely infected MIPs to study their fitness.
These selected clones were first analyzed for divergence as
described earlier, and the results for MIP 2660 are shown in
Fig. 3C and D. For the acutely infected MIP 2660, the diver-
gences between maternal and infant env are similar (median,
0.002) (Fig. 3C and D). Although there is a slight difference in
the two subsets, no above-average divergence value was ob-
served. This confirmed that the selected clones were represen-
tative of the virus population. Similar results were obtained for
MIP 834 (data not shown). Pairwise competitions of recombi-
nant viruses obtained from selected clones from two acutely
infected MIPs, 834 and 2660, were then performed. The fitness
of the viruses conveying the acutely infected infant V1-V5
sequences demonstrated variable fitness in competitions with
maternal variants; in some cases the infant was the winner, and
in others it was the loser. For example with MIP 834, infant
virus i4-3 was more fit than any maternal variant, whereas i4-2
virus was less fit (Fig. 5E and Table 4). There was no significant
difference between infant and maternal viruses (P 	 0.05,
Student paired t test) for all except one MIP (i4-3 versus
M4-2). Similar results were obtained with MIP 2660 (Fig. 5F;
see also Table S5 in the supplemental material). The fitness
differences (Wd) between the viruses from infant and mother
were not always 	1; some Wd values were 1. Moreover, the
results were not cell type dependent since using PBMC as
target cells for infection yielded similar results (Table 5). These
TABLE 3. Fitness value differences from cross-competitions
between nonidentical MIPs
Maternal
virus
Wd of the indicated infant virus relative to the
corresponding maternal virusa
1084 i6-2 2617 i2-1 2669 i2-1 1449 i2-2 2873 i2-4
2873 M0-1 0.92 1.17 0.57 0.96 2.8
1084 M0-4 4.26 0.4 1.06 0.73 1.24
2617 M0-2 0.43 1.9 0.75 0.67 0.65
1449 M0-3 1 0.71 1.14 2.23 0.9
2669 M0-2 2 0.9 3 0.87 1.17
a See Materials and Methods for the calculation of Wd. A Wd of 	1 indicates
that the virus from infant was more fit than the virus from mother; a Wd of 1
indicates that the virus from the infant was less fit than the virus from the mother.
TABLE 4. Relative fitness value from pairwise competition of
viruses from acutely infected MIP 834 in
U87-CD4-CCR5 cellsa
Pair no. and
virus variant W SD Wd P
Pair 1
M4-1 1.08 0.04 0.85 0.12
i4-2 0.92 0.04
Pair 2
M4-1 0.85 0.07 1.38 0.13
i4-3 1.17 0.11
Pair 3
M4-2 1.17 0.06 0.71 0.06
i4-2 0.83 0.06
Pair 4
M4-2 0.91 0.02 1.18 0.04
i4-3 1.08 0.02
Pair 5
M4-3 1.05 0.04 0.87 0.33
i4-2 0.92 0.04
Pair 6
M4-3 0.9 0.06 1.2 0.17
i4-3 1.09 0.06
a The W values and standard deviations (SD) were derived from triplicate
competition assays as shown in Fig. 5E. For an explanation of the other values,
see the footnote to Table 1.
TABLE 5. Relative fitness values from pairwise competition of
viruses from acutely infected MIP 834 in PBMC
Pair no. and
virus variant W SD Wd P
Pair 1
M4-1 1.08 0.06 0.85 0.14
i4-2 0.92 0.06
Pair 2
M4-1 0.75 0.07 1.67 0.02
i4-3 1.25 0.07
Pair 3
M4-2 1.07 0.02 0.87 0.02
i4-2 0.93 0.02
Pair 4
M4-2 0.93 0.06 1.15 0.16
i4-3 1.07 0.06
Pair 5
M4-3 1.29 0.11 0.54 0.05
i4-2 0.7 0.11
Pair 6
M4-3 0.9 0.06 1.22 0.1
i4-3 1.1 0.06
a The W values and standard deviations (SD) were derived from triplicate
competition assays. For an explanation of the other values, see the footnote to
Table 1.
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findings suggest that multiple Env variants are transmitted to
the child perinatally if the mother is acutely infected.
DISCUSSION
In this study we have characterized the replicative fitness of
perinatally transmitted viruses from chronically infected moth-
ers and compared this with MIPs where perinatal transmission
occurred when the mothers were acutely infected. Our results
demonstrated that recombinant viruses containing Env V1-V5
regions derived from the infant viruses possessed a growth
advantage over those derived from their chronically infected
mothers. This advantage was seen in all five MIPs where
chronically infected mothers transmitted their viruses to their
infants but not from two MIPs evincing acute infection. Inter-
estingly, these differences in the transmission phenotypes di-
rectly correlate with the viral genetic diversity near the time of
transmission. The transmitted viruses from the chronically in-
fected MIPs are more homogeneous due to a bottleneck trans-
mission of a subset of the maternal quasispecies, similar to
what other studies observed during perinatal and adult trans-
missions (12, 37). In contrast, the transmitted viruses from the
acutely infected mothers are similar to the maternal quasispe-
cies and did not result in a reduction in viral diversity during
transmission.
There are a number of possible explanations to account for
our observation that a minor viral population within the chron-
ically infected mothers is transmitted. One is that only a minor
population of the transmitted virus is infectious or replication
competent in the new host (23, 34, 36, 40). A second is that the
initial target cells restrict the replication of most transmitted
viral genotypes. It has been postulated that macrophages,
present in the mucosa and placental tissues, may be the first
target cells that HIV-1 encounters and may select for a viral
population that can preferentially infect these cells (6). The
selective transmission could also be an outcome of immune
selection by maternal antibodies. These antibodies could in-
clude neutralizing antibodies, which may play a role in limiting
the transmission of neutralization-sensitive variants. Other
studies using a macaque perinatal transmission model found
that the infant viruses represent minor variants in their moth-
ers and are more neutralization resistant (15, 16). Therefore, it
is difficult to determine whether the transmission of more fit
viruses to the infants is due to selective transmission or selec-
tive amplification in the recipient. In the five MIPs where
mothers were chronically infected with HIV-1, most of the
perinatally transmitted infants’ specimens were obtained be-
fore 2 months of age except 1084i, which was obtained at 6
months. It is unlikely that the infants’ immune systems mediate
the selection since they are not yet fully developed. However,
the maternal passive antibody that has neutralizing activity
might play a role in selective amplification, in which minor
variants were selectively amplified even though multiple HIV-1
variants might be perinatally transmitted, but not all studies
are in agreement on the role of neutralizing antibodies in
HIV-1 perinatal transmission. Maternal antibodies are known
to cross the placenta beginning at 18 weeks of gestation to peak
at delivery; antibodies persist in the infant for up to 18 month
of age and may thus act to prevent HIV-1 infection in the
infant both in utero and postpartum (9). In addition, during
intrapartum exposure, major variants would be neutralized by
passively transferred autologous neutralizing antibodies. How-
ever, minor variants which are resistant would be transmitted
in the absence of broadly neutralizing antibodies, as suggested
by Barin et al. (5). This possibility supports our data that only
a subset of viruses with higher fitness, more adapted for trans-
mission, was selected during perinatal transmission from the
chronically infected mothers. This higher fitness may enable
the transmitted virus to establish initial sites of replication (a
beachhead) or to produce more progeny rapidly to adapt to
growth in vivo and withstand the selection pressures imposed
by perinatal transmission. Whether this subset of the viruses
that we analyzed here is more resistant to neutralization needs
to be determined. In contrast, in acutely infected mothers
whose viruses had recently been selected during transmission,
the viruses required no further selection during perinatal trans-
mission, and viruses from both the mothers and infants had
equal fitness, as we have observed. However, for the infants
born to the chronically infected mothers analyzed, we do not
know whether they were infected in utero, intrapartum, or
postpartum via breast milk; further studies will be needed to
determine whether selective transmission from chronically in-
fected mothers is dependent on the route of transmission.
Although the growth competition assay used in our study
uses a well-established methodology (38), recombination be-
tween the two competing viruses remained a concern. To ad-
dress this concern, viral stocks were serially diluted to the
minimal MOI to reduce the possibility of recombination be-
tween the two competing viruses. If recombination had been a
problem, we would not have observed the consistently higher
fitness of infant viruses. Another constraint is the small num-
ber of clones that were analyzed from each patient. This is due
to the limited number of archived clones analyzed previously
that were available for this study (41), and the clones were
derived from PBMC rather than from plasma. Unfortunately,
patient specimens such as plasma and PBMC DNA are no
longer available to generate additional clones for further anal-
yses, but quantitative analysis of Env V1-V5 divergence dem-
onstrated that our available clones were representative of the
virus population in our study. An additional constraint is that
the clones were generated previously from the pooling of sev-
eral bulk PCRs rather than from the single-genome PCR that
has been used recently (32), and there is a possibility that the
clones were generated from template resampling. However,
our previous studies showed that the number of unique se-
quences is large and is similar at each time point (14, 41),
suggesting that pooling individual PCR products is adequate to
prevent virus template resampling in our study. If resampling
were a problem, we would not have observed differences be-
tween the chronic and acute MIPs.
Selection of a minor viral genotype during perinatal trans-
mission has been reported previously (3, 40); however, no
report has correlated the restricted transmission of viral env
genotypes to their biological properties. Our competition stud-
ies, which employed maternal and infant recombinant viruses
that are identical except for the env V1-V5 region, suggest that
this region of the HIV-1 env conferred the differences in fitness
between the mother and infant viruses. However, we could not
exclude the possibility that other viral genes such as gag and pol
may also play a role in viral fitness. We also could not exclude
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the possibility that the chimeric Env in the NL4.3 backbone
may confer differences in fitness compared to the native non-
chimeric structure. However, this effect should be similar for
all recombinant viruses generated from both chronic and acute
MIPs. The notion that differences were observed between the
chronic and acute MIPs suggests that higher replicative fitness
was determined by the Env V1-V5. Since Env is involved in the
viral entry process, differences in the fitness profiles of mother
and infant viruses indicate that a majority of the maternal
viruses may be less efficient in entry, either in binding or fusion
kinetics or both, and confer a fitness disadvantage compared to
a minor population that was transmitted perinatally. At this
point it is not clear whether superior fitness is due to more
efficient viral entry by the transmitted viruses or whether
postentry events may also have an effect on fitness.
Our study provides the first clear evidence of the higher
fitness of viruses from infants conveyed by env during perinatal
transmission. High fitness of the virus upon transmission to a
new host, in combination with a bottleneck during perinatal
transmission, suggests that during the course of disease pro-
gression in the chronically infected mothers, the majority of
the maternal viruses may have evolved or been selected for
growth and persistence in the host but that only a minor pop-
ulation has retained its fitness for perinatal transmission. It is
possible that this selection occurs in the female reproductive
tract or breast. Whether such a selection occurs during sexual
or blood-borne transmission needs to be determined. This
finding may provide important information for the develop-
ment of a vaccine to prevent perinatal transmission.
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